Mucociliary clearance: Pathophysiological aspects

Clinical Physiology and Functional Imaging

Volumn 34, Issue 3, 2014, Pages 171-177

  Munkholm, Mathias ^a   Mortensen, Jann ^a,b  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b Faroese National Hospital   (Faroe Islands)

Author keywords

Cough clearance; Diagnostic test; Mucociliary clearance; Overview

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MANNITOL; SODIUM CHLORIDE; RESPIRATORY TRACT AGENT;

ANATOMY; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIARY DYSKINESIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; CYSTIC FIBROSIS; DENMARK; DIAGNOSTIC TEST; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; LUNG DISEASE; MUCOCILIARY CLEARANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL; ANIMAL; DRUG EFFECTS; LUNG; LUNG DISEASES; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; HUMANS; LUNG; LUNG DISEASES; MUCOCILIARY CLEARANCE; RESPIRATORY SYSTEM AGENTS; TREATMENT OUTCOME;

EID: 84898598655     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/cpf.12085     Document Type: Article

References (49)

1. Afzelius BA. Cilia-related diseases. J Pathol (2004); 204: 470-477.
2. Amirav I, Cohen-Cymberknoh M, Shoseyov D, Kerem E. Primary ciliary dyskinesia: prospects for new therapies, building on the experience in cystic fibrosis. Paediatr Respir Rev (2009); 10: 58-62.
3. Bennett WD. Effect of beta-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol (2002); 110: S291-S297.
4. Bennett WD, Daviskas E, Hasani A, Mortensen J, Fleming J, Scheuch G. Mucociliary and cough clearance as a biomarker for therapeutic development. J Aerosol Med Pulm Drug Deliv (2010); 23: 261-272.
5. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med (2008); 14: 595-599.
6. Bosse Y, Riesenfeld EP, Pare PD, Irvin CG. It's not all smooth muscle: non-smooth-muscle elements in control of resistance to airflow. Annu Rev Physiol (2010); 72: 437-462.
7. Boucher RC. Cystic fibrosis: a disease of vulnerability to airway surface dehydration. Trends Mol Med (2007); 13: 231-240.
8. Bush A, Chodhari R, Collins N, Copeland F, Hall P, Harcourt J, Hariri M, Hogg C, Lucas J, Mitchison HM, O'Callaghan C, Phillips G. Primary ciliary dyskinesia: current state of the art. Arch Dis Child (2007); 92: 1136-1140.
9. Button B, Cai LH, Ehre C, Kesimer M, Hill DB, Sheehan JK, Boucher RC, Rubinstein M. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science (2012); 337: 937-941.
10. Calderon-Garciduenas L, Valencia-Salazar G, Rodriguez-Alcaraz A, Gambling TM, Garcia R, Osnaya N, Villarreal-Calderon A, Devlin RB, Carson JL. Ultrastructural nasal pathology in children chronically and sequentially exposed to air pollutants. Am J Respir Cell Mol Biol (2001); 24: 132-138.
11. Carson JL, Collier AM, Hu SC. Ultrastructural observations on cellular and subcellular aspects of experimental Mycoplasma pneumoniae disease. Infect Immun (1980); 29: 1117-1124.
12. Chodhari R, Mitchison HM, Meeks M. Cilia, primary ciliary dyskinesia and molecular genetics. Paediatr Respir Rev (2004); 5: 69-76.
13. Escudier E, Duquesnoy P, Papon JF, Amselem S. Ciliary defects and genetics of primary ciliary dyskinesia. Paediatr Respir Rev (2009); 10: 51-54.
14. Evans SE, Xu Y, Tuvim MJ, Dickey BF. Inducible innate resistance of lung epithelium to infection. Annu Rev Physiol (2010); 72: 413-435.
15. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med (2010); 363: 2233-2247.
16. Goeminne P, Dupont L. Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. Postgrad Med J (2010); 86: 493-501.
17. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet (2004); 364: 709-721.
18. Ilowite J, Spiegler P, Chawla S. Bronchiectasis: new findings in the pathogenesis and treatment of this disease. Curr Opin Infect Dis (2008); 21: 163-167.
19. Javidan-Nejad C, Bhalla S. Bronchiectasis. Radiol Clin North Am (2009); 47: 289-306.
20. King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis (2009); 4: 411-419.
21. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest (2002); 109: 571-577.
22. Kondo M, Tamaoki J, Takeyama K, Isono K, Kawatani K, Izumo T, Nagai A. Elimination of IL-13 reverses established goblet cell metaplasia into ciliated epithelia in airway epithelial cell culture. Allergol Int (2006); 55: 329-336.
23. Lester MK, Flume PA. Airway-clearance therapy guidelines and implementation. Respir Care (2009); 54: 733-750; discussion 751-733.
24. Livraghi A, Randell SH. Cystic fibrosis and other respiratory diseases of impaired mucus clearance. Toxicol Pathol (2007); 35: 116-129.
25. Lommatzsch M. Airway hyperresponsiveness: new insights into the pathogenesis. Semin Respir Crit Care Med (2012); 33: 579-587.
26. Mall MA. Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models. J Aerosol Med Pulm Drug Deliv (2008); 21: 13-24.
27. Marthin JK, Mortensen J, Pressler T, Nielsen KG. Pulmonary radioaerosol mucociliary clearance in diagnosis of primary ciliary dyskinesia. Chest (2007); 132: 966-976.
28. Marthin JK, Petersen N, Skovgaard LT, Nielsen KG. Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study. Am J Respir Crit Care Med (2010); 181: 1262-1268.
29. Meeks M, Bush A. Primary ciliary dyskinesia (PCD). Pediatr Pulmonol (2000); 29: 307-316.
30. Miravitlles M, Marin A, Monso E, Vila S, de la Roza C, Hervas R, Esquinas C, Garcia M, Millares L, Morera J, Torres A. Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease. Respir Res (2010); 11: 58.
31. Mortensen J, Falk M, Groth S, Jensen C. The effects of postural drainage and positive expiratory pressure physiotherapy on tracheobronchial clearance in cystic fibrosis. Chest (1991a); 100: 1350-1357.
32. Mortensen J, Groth S, Lange P, Hermansen F. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler. Thorax (1991b); 46: 817-823.
33. Mortensen J, Lange P, Nyboe J, Groth S. Lung mucociliary clearance. Eur J Nucl Med (1994); 21: 953-961.
34. Porter ME, Johnson KA. Dynein structure and function. Annu Rev Cell Biol (1989); 5: 119-151.
35. Pryor JA. Physiotherapy for airway clearance in adults. Eur Respir J (1999); 14: 1418-1424.
36. Randell SH, Boucher RC. Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol (2006); 35: 20-28.
37. Rautiainen M, Nuutinen J, Kiukaanniemi H, Collan Y. Ultrastructural changes in human nasal cilia caused by the common cold and recovery of ciliated epithelium. Ann Otol Rhinol Laryngol (1992); 101: 982-987.
38. Reimer A, Klementsson K, Ursing J, Wretlind B. The mucociliary activity of the respiratory tract. I. Inhibitory effects of products of Pseudomonas aeruginosa on rabbit trachea in vitro. Acta Otolaryngol (1980); 90: 462-469.
39. Robinson M, Eberl S, Tomlinson C, Daviskas E, Regnis JA, Bailey DL, Torzillo PJ, Menache M, Bye PT. Regional mucociliary clearance in patients with cystic fibrosis. J Aerosol Med (2000); 13: 73-86.
40. Rogers DF. Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options. Pulm Pharmacol Ther (2005); 18: 1-8.
41. Rubin BK. Mucus, phlegm, and sputum in cystic fibrosis. Respir Care (2009); 54: 726-732; discussion 732.
42. Sagel SD, Davis SD, Campisi P, Dell SD. Update of respiratory tract disease in children with primary ciliary dyskinesia. Proc Am Thorac Soc (2011); 8: 438-443.
43. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005); 60: 925-931.
44. Stenbit AE, Flume PA. Pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med (2011); 17: 442-447.
45. Tarran R, Grubb BR, Gatzy JT, Davis CW, Boucher RC. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol (2001); 118: 223-236.
46. Wang LF, White DR, Andreoli SM, Mulligan RM, Discolo CM, Schlosser RJ. Cigarette smoke inhibits dynamic ciliary beat frequency in pediatric adenoid explants. Otolaryngol Head Neck Surg (2012); 146: 659-663.
47. Wanner A, Salathe M, O'Riordan TG. Mucociliary clearance in the airways. Am J Respir Crit Care Med (1996); 154: 1868-1902.
48. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Doring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002); 109: 317-325.
49. Yoo Y, Koh YY. Current treatment for primary ciliary dyskinesia conditions. Expert Opin Pharmacother (2004); 5: 369-377.